Vitamin D and Fish Oil Supplements Show Targeted Health Benefits in Landmark Study

A major study has revealed new insights into the benefits of vitamin D and fish oil supplements. The findings suggest these supplements may play a role in reducing cancer deaths and heart attack risks—but only for certain groups. Researchers presented the results at the North American Menopause Society Annual Meeting in Chicago.

The Vitamin D and Omega-3 Trial (VITAL) tracked participants taking daily vitamin D (2,000 IU) or omega-3 fatty acids to assess their impact on cancer and heart disease. Over at least two years, vitamin D did not lower the risk of major cardiovascular events. However, it was linked to a 25% drop in cancer deaths—though this benefit applied only to those of average weight, not individuals with overweight or obesity.

Fish oil supplements, meanwhile, showed a clear advantage in heart health. Participants taking omega-3s had a lower risk of heart attack, particularly those who ate less than 1.5 servings of fish per week. The study aligns with long-held beliefs about the Mediterranean diet, which emphasises fish and nuts rich in omega-3s. Despite these findings, no vitamin was proven to prevent heart disease outright. Experts stress the importance of managing other risk factors, such as high cholesterol, smoking, hypertension, and diabetes. Further research is still needed to pinpoint which groups benefit most from these supplements. For now, those already taking vitamin D can continue safely, provided they stay within the recommended 4,000 IU daily limit.

The VITAL trial highlights specific benefits of vitamin D and fish oil, but with limitations. Vitamin D may cut cancer deaths in some individuals, while fish oil could lower heart attack risks for those with low fish consumption. Researchers will continue exploring how these supplements might best support long-term health.